Psychiatry and Neurology, Neurology · Jacksonville, FL
NPI
1851360887
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
580 W 8th St, Ufjp Neurology
Jacksonville, FL, 32209
Phone (904) 244-3960
Groups this clinician bills Medicare through
Medicare paid, 2024
$55K
1,922 services
Medicare patients, 2024
259
Average age 71
Drug cost, 2024
$9.9M
2,275 prescriptions
Company payments, 2025
$7,187
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael T Pulley was code 99215 (office e&m - established), 108 times for 81 patients. In total Michael T Pulley billed 1,922 services in 36 codes, and Medicare paid $55K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-06-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 108 | 81 | $104.63 | $11K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 80 | 53 | $12.74 | $1,019 |
| 99214 Office E&M - Established | Facility | 68 | 51 | $66.94 | $4,552 |
| 95885 Electrical Nerve Conductivity | Facility | 65 | 61 | $13.78 | $896 |
| 95885 Electrical Nerve Conductivity | Office | 54 | 49 | $46.08 | $2,488 |
| 95911 Electrical Nerve Conductivity | Facility | 50 | 49 | $98.36 | $4,918 |
| 95911 Electrical Nerve Conductivity | Office | 38 | 37 | $140.66 | $5,345 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 24 | 21 | $24.55 | $589 |
| 99213 Office E&M - Established | Facility | 22 | 19 | $46.95 | $1,033 |
| 99205 Office E&M - New | Facility | 20 | 20 | $123.34 | $2,467 |
| 99202 Office E&M - New | Facility | 18 | 18 | $35.32 | $636 |
| 95912 Electrical Nerve Conductivity | Facility | 16 | 16 | $110.71 | $1,771 |
| 95912 Electrical Nerve Conductivity | Office | 12 | 12 | $179.53 | $2,154 |
By year: 2022 $79K for 3,166 services; 2023 $71K for 3,728 services; 2024 $55K for 1,922 services.
Medicare prescription drug claims, 2024
In 2024, the drug Michael T Pulley prescribed most often to Medicare patients was Prednisone, with 551 prescriptions and refills. In total Michael T Pulley wrote 2,275 Medicare prescriptions that cost $9.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 551 | 747 | 72 | $2,407 |
| Mycophenolate Mofetil Generic | 153 | 220 | 28 | $50K |
| Radicava Ors Edaravone | 119 | 119 | 18 | $1.7M |
| Methotrexate Methotrexate Sodium | 105 | 174 | 18 | $1,740 |
| Pyridostigmine Bromide Generic | 104 | 207 | 36 | $8,403 |
| Gabapentin Generic | 95 | 175 | 23 | $2,068 |
| Riluzole Generic | 94 | 128 | 22 | $10K |
| Sodium Chloride 0.9 % Sodium Chloride | 63 | 65 | 11 | $211 |
| Privigen Immun Glob G(Igg)/Pro/Iga 0-50 | 57 | 61 | Under 11 | $822K |
| Duloxetine Hcl Generic | 49 | 103 | 16 | $625 |
| Gamunex-C Immune Globul G/Gly/Iga Avg 46 | 48 | 48 | Under 11 | $104K |
| Tramadol Hcl Generic | 47 | 47 | Under 11 | $135 |
| Baclofen Generic | 39 | 65 | Under 11 | $355 |
| Ultomiris Ravulizumab-Cwvz | 38 | 61 | Under 11 | $2.3M |
| Folic Acid Generic | 38 | 62 | Under 11 | $197 |
Brand drugs: - claims; generic drugs: 1,715 claims; opioid claims: 141.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael T Pulley $7,187 ($7,187 in general payments such as food, travel and fees) from 10 companies. The largest payer was Janssen Biotech, Inc. with $2,220.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 1 | $2,220 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 9 | $2,105 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. 4578.T | 1 | $1,200 |
| Vertex Pharmaceuticals Incorporated VRTX | 2 | $792 |
| CSL Behring CSL.AX | 3 | $376 |
| BioCryst Pharmaceuticals, Inc. BCRX | 1 | $290 |
| Alexion Pharmaceuticals, Inc. AZN | 1 | $175 |
| EMD Serono, Inc. MRK.DE | 1 | $28.91 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.